BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mark Evenstad Assumes Responsibilities Of President And COO Of Upsher-Smith Laboratories


10/19/2005 5:10:12 PM

MAPLE GROVE, Minn., Nov. 3 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announced today that Mark B. Evenstad will assume the roles and responsibilities of President and Chief Operating Officer of the company, effective immediately. Evenstad takes on this role following the recent retirement of President Ian Troup.

"We are very fortunate to have had Ian's expertise and guidance at Upsher-Smith," says Evenstad. "His years of dedication have been instrumental in bringing the company to this point and we are extremely grateful for his years of service." Troup will remain available to the company as a consultant through the year's end to ensure a smooth transition.

"Mark's role is an affirmation of our family's ongoing commitment to this company," says Ken Evenstad. "As a second-generation leader and Vice Chairman he has made a significant contribution to the growth of Upsher-Smith and has shown a vigorous commitment to innovation and excellence. His leadership will continue to be an asset to the company."

"I am excited about taking on this operational role and continuing to create ongoing value for our customers, suppliers and employees," says Mark Evenstad. "Upsher-Smith has experienced tremendous growth in the past several years and we are on a path for ongoing success. We will continue to energetically develop our brand, launch new products and provide superior solutions and services for our customers."

Mark Evenstad will concentrate on the company's growth while remaining focused on its core strengths, which include the development of new products, a highly sophisticated sales and marketing force and its excellent relationship with the FDA. He will also lead the company in originating new drug therapies and exploring potential acquisitions. He will continue to work closely with his father, Ken Evenstad, CEO and Chairman of the Board.

Mark Evenstad is a member of the Young Presidents' Organization and the Licensing Executives Society. He is a graduate of the University of St. Thomas, St. Paul, Minn.

About Upsher-Smith Laboratories. Founded in 1919, Upsher-Smith Laboratories, Inc. is a rapidly growing, fully integrated pharmaceutical company and a recognized leader in the sales and marketing of cardiovascular and dermatological products. The company develops, manufactures and markets prescription pharmaceutical products. For more information about Upsher-Smith Laboratories, call 1.800.328.3344 or visit http://www.upsher-smith.com/ .

Website: http://www.upsher-smith.com

Upsher-Smith Laboratories, Inc.

CONTACT: Rebecca Lunna, Periscope PR for Upsher-Smith Laboratories, Inc.+1-612-399-0697



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES